Incretin & metabolic
AOD-9604
- 10 mg
Custom strengths on request
Not FDA-approved. Not on FDA's 503A category lists (May 14, 2026). Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
0.25 mg oral tablet daily (lowest fixed arm, phase IIb trial; no titration)
Human studyCeiling
1 mg oral tablet daily (top arm here; oral capsules to 30 mg daily also studied)
Human study
- Frequency
- daily
- Route
- oral (tablets); no subcutaneous dosing trial found
- Course
- 24 weeks after a 4-week placebo run-in
Trial doses were oral or intravenous only; never convert them to subcutaneous doses. Practice figures for subcutaneous use are convention, not evidence.
Get a quote
Custom strengths on request. Prices are quoted per clinic.